Skip to main content
SpringerLink
Log in

Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction

  • Published:
Quality of Life Research Aims and scope Submit manuscript

Abstract

The aim of the present study was to evaluate the efficacy of sildenafil citrate and its effects on quality of life (QoL) in men with erectile dysfunction (ED) using data from three multicenter, double-blind, placebo-controlled clinical trials. Efficacy was evaluated using a global efficacy question (improvement of erections) and questions from the International Index of Erectile Function (IIEF) addressing the ability to achieve and maintain erections. QoL directly related to ED was evaluated using questions 13 and 14 of the IIEF, several psychometric instruments, and a questionnaire addressing men's concerns about their erection problems. Ninety-seven percent of patients receiving sildenafil reported improved erections compared with 23% of patients receiving placebo (p < 0.0001); also reported were improvements in the ability to achieve and maintain erections with sildenafil but not with placebo (p < 0.0001). Improvements were also seen for other aspects of sexual function (overall satisfaction with sex life, sexual relationships with partners, concerns about erectile problems; p < 0.0001) and general mental health (well-being, self-control, satisfaction with relationship, health relative to 1 year ago, mental health; p ≤ 0.05) following treatment with sildenafil. Thus, treatment of ED with sildenafil can significantly improve key QoL parameters related to sexual dysfunction and general mental health.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. NIH Consensus Development Panel on Impotence: Impotence. JAMA 1993; 270: 83–90.

    Google Scholar 

  2. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, Naylor AM. Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 1998; 159: 2164–2171.

    Article  PubMed  CAS  Google Scholar 

  3. Boolell M, Allen MJ, Ballard SA, et al. Sildenafil: An orally active type 5 cyclic GMP-specific phosphodiesterase inhibitor for the treatment of penile erectile dysfunction. Int J Impot Res 1996; 8: 47–52.

    PubMed  CAS  Google Scholar 

  4. Padma-Nathan H, Steers WD, Wicker PA (for the Sildenafil Study Group). Efficacy and safety of oral sildenafil in the treatment of erectile dysfunction: A double-blind, placebo-controlled study of 329 patients. Int J Clin Pract 1998; 52: 375–380.

    PubMed  CAS  Google Scholar 

  5. Morales A, Gingell C, Collins M, Wicker PA, Osterloh IH. Clinical safety of oral sildenafil citrate (VIAGRA) in the treatment of erectile dysfunction. Int J Impot Res 1998; 10: 69–74.

    Article  PubMed  CAS  Google Scholar 

  6. Marks LS, Duda C, Dorey FJ, Macairan ML, Santos PB. Treatment of erectile dysfunction with sildenafil. Urology 1999; 53: 19–24.

    Article  PubMed  CAS  Google Scholar 

  7. Fugl-Meyer AR, Lodnert G, Branholm IB, Fugl-Meyer KS. On life satisfaction in male erectile dysfunction. Int J Impot Res 1997; 9: 141–148.

    Article  PubMed  CAS  Google Scholar 

  8. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Impotence and its medical and psychosocial correlates: Results of the Massachusetts Male Aging Study. J Urol 1994; 151: 54–61.

    PubMed  CAS  Google Scholar 

  9. Jonler M, Moon T, Brannan W, Stone NN, Heisey D, Bruskewitz RC. The effect of age, ethnicity and geographical location on impotence and quality of life. Br J Urol 1995; 75: 651–655.

    Article  PubMed  CAS  Google Scholar 

  10. Wagner TH, Patrick DL, McKenna SP, Froese PS. Cross-cultural development of a quality of life measure for men with erection difficulties. Qual Life Res 1996; 5: 443–449.

    Article  PubMed  CAS  Google Scholar 

  11. Gheorghiu S, Godschalk M, Gentili A, Mulligan T. Quality of life in patients using self-administered intracavernous injections of prostaglandin El for erectile dysfunction. J Urol 1996; 156: 80–81.

    Article  PubMed  CAS  Google Scholar 

  12. Ehrensaft MK, Condra M, Morales A, Heaton J. Communication patterns in patients with erectile dysfunction and their partners. Int J Impot Res 1994; 6: 25–32.

    PubMed  CAS  Google Scholar 

  13. Willke RJ, Glick HA, McCarron TJ, Erder MH, Althof SE, Linet OI. Quality of life effects of alprostadil therapy for erectile dysfunction. J Urol 1997; 157: 2124–2128.

    Article  PubMed  CAS  Google Scholar 

  14. Perez MA, Meyerowitz BE, Lieskovsky G, Skinner DG, Reynolds B, Skinner EC. Quality of life and sexuality following radical prostatectomy in patients with prostate cancer who use or do not use erectile aids. Urology 1997; 50: 740–746.

    Article  PubMed  CAS  Google Scholar 

  15. Montorsi F, McDermott TED, Morgan R, et al. Efficacy and safety of fixed-dose oral sildenafil in the treatment of erectile dysfunction of various etiologies. Urology 1999; 53: 1011–1018.

    Article  PubMed  CAS  Google Scholar 

  16. Dinsmore WW, Hodges M, Hargreaves C, Osterloh IH, Smith MD, Rosen RC. Sildenafil citrate (VIAGRA) in erectile dysfunction: Near normalization in men with broad-spectrum erectile dysfunction compared with age-matched healthy control subjects. Urology 1999; 53: 800–805.

    Article  PubMed  CAS  Google Scholar 

  17. Meuleman E, Cuzin B, Opsomer RJ, et al. A dose-escalation study to assess the efficacy and safety of VIAGRA® (sildenafil citrate) in men with erectile dysfunction. BJU Int 2001; 87: 75–81.

    Article  PubMed  CAS  Google Scholar 

  18. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The International Index of Erectile Function (IIEF): A multidimensional scale for assessment of erectile dysfunction. Urology 1997; 49: 822–830.

    Article  PubMed  CAS  Google Scholar 

  19. Fava M, Rankin MA, Alpert JE, Nierenberg AA, Worthington JJ. An open trial of oral sildenafil in antidepressant-induced sexual dysfunction. Psychother Psychosom 1998; 67: 328–331.

    Article  PubMed  CAS  Google Scholar 

  20. Feighner J, Targum SD, Bennett ME, et al. A double-blind, placebo-controlled trial of nefazodone in the treatment of patients hospitalized for major depression. J Clin Psychiatry 1998; 59: 246–253.

    PubMed  CAS  Google Scholar 

  21. Feldman HA, Goldstein I, Hatzichristou DG, Krane RJ, McKinlay JB. Construction of a surrogate variable for impotence in the Massachusetts Male Aging Study. J Clin Epidemiol 1994; 47: 457–467.

    Article  PubMed  CAS  Google Scholar 

  22. Ware JE, Sherbourne CD. The MOS 36–item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care 1992; 30: 473–483.

    PubMed  Google Scholar 

  23. Stewart AL, Hays RD, Ware JE. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988; 26: 724–735.

    PubMed  CAS  Google Scholar 

  24. Neugarten BL, Havighurst RJ, Tobin SS. The measurement of life satisfaction. J Gerontol 1961; 16: 134–143.

    PubMed  CAS  Google Scholar 

  25. Stewart AL, Ware JE. Measuring Functioning and Well-being: The Medical Outcomes Study Approach. Durham, North Carolina: Duke University Press, 1992.

    Google Scholar 

  26. Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA. Oral sildenafil in the treatment of erectile dysfunction. N Engl J Med 1998; 338: 1397–1404.

    Article  PubMed  CAS  Google Scholar 

  27. Rendell MS, Rajfer J, Wicker PA, Smith MD, for the Sildenafil Diabetes Study Group. Sildenafil for treatment of erectile dysfunction in men with diabetes. JAMA 1999; 281: 421–426.

    Article  PubMed  CAS  Google Scholar 

  28. Giuliano F, Hultling C, El Masry WS, et al. Randomized trial of sildenafil for the treatment of erectile dysfunction in spinal cord injury. Ann Neurol 1999; 46: 15–21.

    Article  PubMed  CAS  Google Scholar 

  29. Litwin MS, Nied RJ, Dhanani N. Health-related quality of life in men with erectile dysfunction. J Gen Intern Med 1998; 13: 159–166.

    Article  PubMed  CAS  Google Scholar 

  30. Williams G, Abbou CC, Amar ET, et al. The effect of transurethral alprostadil on the quality of life of men with erectile dysfunction, and their partners. MUSE Study Group. Br J Urol 1998; 82: 847–854.

    Google Scholar 

  31. Rosen RC. Quality of life assessment in sexual dysfunction trials. Int J Impot Res 1998; 10(Suppl 2): S21–S23.

    PubMed  Google Scholar 

  32. Bates TS, Wright MP, Gillatt DA. Prevalence and impact of incontinence and impotence following total prostatectomy assessed anonymously by the ICS-male questionnaire. Eur Urol 1998; 33: 165–169.

    Article  PubMed  CAS  Google Scholar 

  33. Hays RD, Sherbourne CD, Mazel RM. The RAND 36–Item Health Survey 1.0 (see comments). Health Econ 1993; 2: 217–227.

    PubMed  CAS  Google Scholar 

  34. Willke RJ, Yen W, Parkerson GR, Linet OI, Erder MH, Glick HA. Quality of life effects of alprostadil therapy for erectile dysfunction: Results of a trial in Europe and South Africa. Int J Impot Res 1998; 10: 239–246.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Urology, CHU de Bicêtre, AP-HP, Le Kremlin Bicêtre, France

    François Giuliano

  2. Pfizer Inc, New York, NY, USA

    Beatriz M. Peña & Avanish Mishra

  3. Pfizer Ltd, Sandwich, England

    Michael D. Smith

Authors
  1. François Giuliano
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Beatriz M. Peña
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Avanish Mishra
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael D. Smith
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Giuliano, F., Peña, B.M., Mishra, A. et al. Efficacy results and quality-of-life measures in men receiving sildenafil citrate for the treatment of erectile dysfunction. Qual Life Res 10, 359–369 (2001). https://doi.org/10.1023/A:1012270220064

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1012270220064

Search

Navigation